so when leronlimab is shown to be even better, wit
Post# of 148628
better is good. i like my drugs to be better. even if leronlimab results are shown to be similar to "standard of care", but has the added benefit of no side effects, unlike the dangerous current drugs that have significant, often black box warning side effects, approval should be granted.
this ship is sailing strong. lets hope the ref is wearing glasses this time.